CASALI, PAOLO GIOVANNI

CASALI, PAOLO GIOVANNI  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 235 (tempo di esecuzione: 0.016 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study 2022 Stacchiotti, SilviaCasali, Paolo Giovanni + Article (author) -
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study 2022 Fumagalli, ElenaCasali, Paolo G + Article (author) -
Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry 2022 Sanfilippo, RobertaCasali, Paolo G + Article (author) -
Rare cancers : not all together in clinical studies! 2022 Casali, P GLicitra, L + Article (author) -
Ethical issues in oncology practice: a qualitative study of stakeholders' experiences and expectations 2022 Chiara CricoVirginia SanchiniPaolo G. CasaliGabriella Pravettoni Article (author) -
Is rare cancer care organized at national health system level? Multiple case study in six EU countries 2022 Casali, Paolo G + Article (author) -
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial 2022 Infante G.Marrari A.Casali P. G. + Article (author) -
Gastrointestinal stromal tumours : ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up 2022 Casali P. G. + Article (author) -
Systemic treatment in advanced phyllodes tumor of the breast : a multi-institutional European retrospective case-series analyses 2022 Casali P. G. + Article (author) -
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) 2022 Casali, Paolo G + Article (author) -
Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature 2022 Nasca, VincenzoBuonomenna, CiriacoCasali, Paolo GiovanniStacchiotti, Silvia + Article (author) -
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib 2022 Stacchiotti, SilviaCasali, Paolo Giovanni + Article (author) -
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆ 2021 Casali P. G. + Article (author) -
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts 2021 Stacchiotti S.Caraceni A.Callegaro D.Molinari M.Casali P. G. + Article (author) -
Data protection and research in the European Union: a major step forward, with a step back 2021 Casali P. G. + Article (author) -
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ☆ 2021 Casali P. G.Stacchiotti S. + Article (author) -
Clinical prognostic factors in advanced epithelioid haemangioendothelioma : a retrospective case series analysis within the Italian Rare Cancers Network 2021 Buonomenna C.Casali P. G.Caraceni A.Infante G.Saita L.Simeone N.Stacchiotti S. + Article (author) -
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature 2021 Brunello A.Casali P. G.Stacchiotti S. + Article (author) -
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up 2021 Casali P. G. + Article (author) -
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation 2021 Pasquali S.Sanfilippo R.Casali P. G.Stacchiotti S. + Article (author) -